Published in News, Funding & opportunities
GACD funds landmark research into prevention and treatment of type 2 diabetes.
Members of the Global Alliance for Chronic Diseases will fund sixteen research projects to prevent and treat type 2 diabetes. The research is to take place in twenty-five low- and middle-income centres across the globe. The projects represent over USD 30 million of research funding over 3-5 years with a focus on implementation and intervention research in low- and middle-income countries, vulnerable populations in high-income countries and aboriginal communities. All nine GACD member agencies have committed funds to the joint diabetes programme.
Dr Xuetao Cao, Chair, GACD: “This collaboration is significant and wide reaching in its scope to address the growing epidemic of chronic non-communicable diseases. By expanding its membership and working together, the GACD has a unique opportunity to evaluate implementation strategies, leverage multiple research investments and provide evidence to guide policy and ultimately reduce the number of deaths from diabetes in developing countries.”
Most research projects are conducted through a partnership between investigators in a developed country institution and investigators and institutions in low- and middle-income countries. The GACD diabetes programme will examine various underlying mechanisms for the control and prevention of type 2 diabetes, such as family and institutional environments, health systems, technology and economic, social and cultural factors, as well as the management of the disease.
According to the International Diabetes Federation, one in ten of the world’s population will have diabetes by 2035. People living with diabetes will surge from 382 million to 592 million people by 2035. The majority of those will live in low- and middle-income countries and most of them will be under 60 years of age.